Loading…

Exploring the Complexity of Death-Censored Kidney Allograft Failure

Few studies have thoroughly investigated the causes of kidney graft loss (GL), despite its importance. A novel approach assigns each persistent and relevant decline in renal function over the lifetime of a renal allograft to a standardized category, hypothesizing that singular or multiple events fin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2021-06, Vol.32 (6), p.1513-1526
Main Authors: Mayrdorfer, Manuel, Liefeldt, Lutz, Wu, Kaiyin, Rudolph, Birgit, Zhang, Qiang, Friedersdorff, Frank, Lachmann, Nils, Schmidt, Danilo, Osmanodja, Bilgin, Naik, Marcel G, Duettmann, Wiebke, Halleck, Fabian, Merkel, Marina, Schrezenmeier, Eva, Waiser, Johannes, Duerr, Michael, Budde, Klemens
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053
cites cdi_FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053
container_end_page 1526
container_issue 6
container_start_page 1513
container_title Journal of the American Society of Nephrology
container_volume 32
creator Mayrdorfer, Manuel
Liefeldt, Lutz
Wu, Kaiyin
Rudolph, Birgit
Zhang, Qiang
Friedersdorff, Frank
Lachmann, Nils
Schmidt, Danilo
Osmanodja, Bilgin
Naik, Marcel G
Duettmann, Wiebke
Halleck, Fabian
Merkel, Marina
Schrezenmeier, Eva
Waiser, Johannes
Duerr, Michael
Budde, Klemens
description Few studies have thoroughly investigated the causes of kidney graft loss (GL), despite its importance. A novel approach assigns each persistent and relevant decline in renal function over the lifetime of a renal allograft to a standardized category, hypothesizing that singular or multiple events finally lead to GL. An adjudication committee of three physicians retrospectively evaluated indication biopsies, laboratory testing, and medical history of all 303 GLs among all 1642 recipients of transplants between January 1, 1997 and December 31, 2017 at a large university hospital to assign primary and/or secondary causes of GL. In 51.2% of the patients, more than one cause contributed to GL. The most frequent primary or secondary causes leading to graft failure were intercurrent medical events in 36.3% of graft failures followed by T cell-mediated rejection (TCMR) in 34% and antibody-mediated rejection (ABMR) in 30.7%. In 77.9%, a primary cause could be attributed to GL, of which ABMR was most frequent (21.5%). Many causes for GL were identified, and predominant causes for GL varied over time. GL is often multifactorial and more complex than previously thought.
doi_str_mv 10.1681/ASN.2020081215
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8259637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33883251</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053</originalsourceid><addsrcrecordid>eNpVkE1PwzAMhiMEYmNw5Yj6BzqS5qPhgjSVDRATHIBzlDTOFtQ1VdpN27-naDDgYluyn9fSg9AlwWMiJLmevD6PM5xhLElG-BEaEk5pShnHx_2MmUiFyOkAnbXtB8aEZ3l-igaUSkkzToaomG6bKkRfL5JuCUkRVk0FW9_tkuCSO9DdMi2gbkMEmzx5W8MumVRVWETtumSmfbWOcI5OnK5auPjuI_Q-m74VD-n85f6xmMzTklHepcw6Qx0ujZSEcy2AcUGZYYZnWkitjbHgSgaSMBCmrz3FuJbSCiIs5nSEbve5zdqswJZQd1FXqol-peNOBe3V_03tl2oRNkpm_EbQvA8Y7wPKGNo2gjuwBKsvnarXqX519sDV34-H8x9_9BMVPXFc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Exploring the Complexity of Death-Censored Kidney Allograft Failure</title><source>PubMed Central (Open Access)</source><source>Elektronische Zeitschriftenbibliothek</source><creator>Mayrdorfer, Manuel ; Liefeldt, Lutz ; Wu, Kaiyin ; Rudolph, Birgit ; Zhang, Qiang ; Friedersdorff, Frank ; Lachmann, Nils ; Schmidt, Danilo ; Osmanodja, Bilgin ; Naik, Marcel G ; Duettmann, Wiebke ; Halleck, Fabian ; Merkel, Marina ; Schrezenmeier, Eva ; Waiser, Johannes ; Duerr, Michael ; Budde, Klemens</creator><creatorcontrib>Mayrdorfer, Manuel ; Liefeldt, Lutz ; Wu, Kaiyin ; Rudolph, Birgit ; Zhang, Qiang ; Friedersdorff, Frank ; Lachmann, Nils ; Schmidt, Danilo ; Osmanodja, Bilgin ; Naik, Marcel G ; Duettmann, Wiebke ; Halleck, Fabian ; Merkel, Marina ; Schrezenmeier, Eva ; Waiser, Johannes ; Duerr, Michael ; Budde, Klemens</creatorcontrib><description>Few studies have thoroughly investigated the causes of kidney graft loss (GL), despite its importance. A novel approach assigns each persistent and relevant decline in renal function over the lifetime of a renal allograft to a standardized category, hypothesizing that singular or multiple events finally lead to GL. An adjudication committee of three physicians retrospectively evaluated indication biopsies, laboratory testing, and medical history of all 303 GLs among all 1642 recipients of transplants between January 1, 1997 and December 31, 2017 at a large university hospital to assign primary and/or secondary causes of GL. In 51.2% of the patients, more than one cause contributed to GL. The most frequent primary or secondary causes leading to graft failure were intercurrent medical events in 36.3% of graft failures followed by T cell-mediated rejection (TCMR) in 34% and antibody-mediated rejection (ABMR) in 30.7%. In 77.9%, a primary cause could be attributed to GL, of which ABMR was most frequent (21.5%). Many causes for GL were identified, and predominant causes for GL varied over time. GL is often multifactorial and more complex than previously thought.</description><identifier>ISSN: 1046-6673</identifier><identifier>EISSN: 1533-3450</identifier><identifier>DOI: 10.1681/ASN.2020081215</identifier><identifier>PMID: 33883251</identifier><language>eng</language><publisher>United States: American Society of Nephrology</publisher><subject>Adult ; Aged ; Allografts - pathology ; Allografts - physiopathology ; Allografts - statistics &amp; numerical data ; Calcineurin Inhibitors - adverse effects ; Cardio-Renal Syndrome - complications ; Clinical Research ; Databases, Factual ; Death ; Female ; Graft Rejection - immunology ; Graft Rejection - prevention &amp; control ; Graft Survival ; Humans ; Immunity, Cellular ; Immunity, Humoral ; Immunosuppressive Agents - therapeutic use ; Kidney Failure, Chronic - surgery ; Kidney Transplantation - standards ; Kidney Transplantation - statistics &amp; numerical data ; Male ; Medication Adherence - statistics &amp; numerical data ; Middle Aged ; Polyomavirus Infections - complications ; Recurrence ; Retrospective Studies ; Survival Rate ; T-Lymphocytes ; Thrombosis - complications ; Time Factors ; Tumor Virus Infections - complications</subject><ispartof>Journal of the American Society of Nephrology, 2021-06, Vol.32 (6), p.1513-1526</ispartof><rights>Copyright © 2021 by the American Society of Nephrology.</rights><rights>Copyright © 2021 by the American Society of Nephrology 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053</citedby><cites>FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053</cites><orcidid>0000-0002-6063-2806 ; 0000-0001-5236-2749 ; 0000-0003-3872-3477 ; 0000-0002-7929-5942 ; 0000-0002-6988-8269</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259637/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259637/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33883251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mayrdorfer, Manuel</creatorcontrib><creatorcontrib>Liefeldt, Lutz</creatorcontrib><creatorcontrib>Wu, Kaiyin</creatorcontrib><creatorcontrib>Rudolph, Birgit</creatorcontrib><creatorcontrib>Zhang, Qiang</creatorcontrib><creatorcontrib>Friedersdorff, Frank</creatorcontrib><creatorcontrib>Lachmann, Nils</creatorcontrib><creatorcontrib>Schmidt, Danilo</creatorcontrib><creatorcontrib>Osmanodja, Bilgin</creatorcontrib><creatorcontrib>Naik, Marcel G</creatorcontrib><creatorcontrib>Duettmann, Wiebke</creatorcontrib><creatorcontrib>Halleck, Fabian</creatorcontrib><creatorcontrib>Merkel, Marina</creatorcontrib><creatorcontrib>Schrezenmeier, Eva</creatorcontrib><creatorcontrib>Waiser, Johannes</creatorcontrib><creatorcontrib>Duerr, Michael</creatorcontrib><creatorcontrib>Budde, Klemens</creatorcontrib><title>Exploring the Complexity of Death-Censored Kidney Allograft Failure</title><title>Journal of the American Society of Nephrology</title><addtitle>J Am Soc Nephrol</addtitle><description>Few studies have thoroughly investigated the causes of kidney graft loss (GL), despite its importance. A novel approach assigns each persistent and relevant decline in renal function over the lifetime of a renal allograft to a standardized category, hypothesizing that singular or multiple events finally lead to GL. An adjudication committee of three physicians retrospectively evaluated indication biopsies, laboratory testing, and medical history of all 303 GLs among all 1642 recipients of transplants between January 1, 1997 and December 31, 2017 at a large university hospital to assign primary and/or secondary causes of GL. In 51.2% of the patients, more than one cause contributed to GL. The most frequent primary or secondary causes leading to graft failure were intercurrent medical events in 36.3% of graft failures followed by T cell-mediated rejection (TCMR) in 34% and antibody-mediated rejection (ABMR) in 30.7%. In 77.9%, a primary cause could be attributed to GL, of which ABMR was most frequent (21.5%). Many causes for GL were identified, and predominant causes for GL varied over time. GL is often multifactorial and more complex than previously thought.</description><subject>Adult</subject><subject>Aged</subject><subject>Allografts - pathology</subject><subject>Allografts - physiopathology</subject><subject>Allografts - statistics &amp; numerical data</subject><subject>Calcineurin Inhibitors - adverse effects</subject><subject>Cardio-Renal Syndrome - complications</subject><subject>Clinical Research</subject><subject>Databases, Factual</subject><subject>Death</subject><subject>Female</subject><subject>Graft Rejection - immunology</subject><subject>Graft Rejection - prevention &amp; control</subject><subject>Graft Survival</subject><subject>Humans</subject><subject>Immunity, Cellular</subject><subject>Immunity, Humoral</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney Failure, Chronic - surgery</subject><subject>Kidney Transplantation - standards</subject><subject>Kidney Transplantation - statistics &amp; numerical data</subject><subject>Male</subject><subject>Medication Adherence - statistics &amp; numerical data</subject><subject>Middle Aged</subject><subject>Polyomavirus Infections - complications</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>Survival Rate</subject><subject>T-Lymphocytes</subject><subject>Thrombosis - complications</subject><subject>Time Factors</subject><subject>Tumor Virus Infections - complications</subject><issn>1046-6673</issn><issn>1533-3450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkE1PwzAMhiMEYmNw5Yj6BzqS5qPhgjSVDRATHIBzlDTOFtQ1VdpN27-naDDgYluyn9fSg9AlwWMiJLmevD6PM5xhLElG-BEaEk5pShnHx_2MmUiFyOkAnbXtB8aEZ3l-igaUSkkzToaomG6bKkRfL5JuCUkRVk0FW9_tkuCSO9DdMi2gbkMEmzx5W8MumVRVWETtumSmfbWOcI5OnK5auPjuI_Q-m74VD-n85f6xmMzTklHepcw6Qx0ujZSEcy2AcUGZYYZnWkitjbHgSgaSMBCmrz3FuJbSCiIs5nSEbve5zdqswJZQd1FXqol-peNOBe3V_03tl2oRNkpm_EbQvA8Y7wPKGNo2gjuwBKsvnarXqX519sDV34-H8x9_9BMVPXFc</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Mayrdorfer, Manuel</creator><creator>Liefeldt, Lutz</creator><creator>Wu, Kaiyin</creator><creator>Rudolph, Birgit</creator><creator>Zhang, Qiang</creator><creator>Friedersdorff, Frank</creator><creator>Lachmann, Nils</creator><creator>Schmidt, Danilo</creator><creator>Osmanodja, Bilgin</creator><creator>Naik, Marcel G</creator><creator>Duettmann, Wiebke</creator><creator>Halleck, Fabian</creator><creator>Merkel, Marina</creator><creator>Schrezenmeier, Eva</creator><creator>Waiser, Johannes</creator><creator>Duerr, Michael</creator><creator>Budde, Klemens</creator><general>American Society of Nephrology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6063-2806</orcidid><orcidid>https://orcid.org/0000-0001-5236-2749</orcidid><orcidid>https://orcid.org/0000-0003-3872-3477</orcidid><orcidid>https://orcid.org/0000-0002-7929-5942</orcidid><orcidid>https://orcid.org/0000-0002-6988-8269</orcidid></search><sort><creationdate>20210601</creationdate><title>Exploring the Complexity of Death-Censored Kidney Allograft Failure</title><author>Mayrdorfer, Manuel ; Liefeldt, Lutz ; Wu, Kaiyin ; Rudolph, Birgit ; Zhang, Qiang ; Friedersdorff, Frank ; Lachmann, Nils ; Schmidt, Danilo ; Osmanodja, Bilgin ; Naik, Marcel G ; Duettmann, Wiebke ; Halleck, Fabian ; Merkel, Marina ; Schrezenmeier, Eva ; Waiser, Johannes ; Duerr, Michael ; Budde, Klemens</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Allografts - pathology</topic><topic>Allografts - physiopathology</topic><topic>Allografts - statistics &amp; numerical data</topic><topic>Calcineurin Inhibitors - adverse effects</topic><topic>Cardio-Renal Syndrome - complications</topic><topic>Clinical Research</topic><topic>Databases, Factual</topic><topic>Death</topic><topic>Female</topic><topic>Graft Rejection - immunology</topic><topic>Graft Rejection - prevention &amp; control</topic><topic>Graft Survival</topic><topic>Humans</topic><topic>Immunity, Cellular</topic><topic>Immunity, Humoral</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney Failure, Chronic - surgery</topic><topic>Kidney Transplantation - standards</topic><topic>Kidney Transplantation - statistics &amp; numerical data</topic><topic>Male</topic><topic>Medication Adherence - statistics &amp; numerical data</topic><topic>Middle Aged</topic><topic>Polyomavirus Infections - complications</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>Survival Rate</topic><topic>T-Lymphocytes</topic><topic>Thrombosis - complications</topic><topic>Time Factors</topic><topic>Tumor Virus Infections - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mayrdorfer, Manuel</creatorcontrib><creatorcontrib>Liefeldt, Lutz</creatorcontrib><creatorcontrib>Wu, Kaiyin</creatorcontrib><creatorcontrib>Rudolph, Birgit</creatorcontrib><creatorcontrib>Zhang, Qiang</creatorcontrib><creatorcontrib>Friedersdorff, Frank</creatorcontrib><creatorcontrib>Lachmann, Nils</creatorcontrib><creatorcontrib>Schmidt, Danilo</creatorcontrib><creatorcontrib>Osmanodja, Bilgin</creatorcontrib><creatorcontrib>Naik, Marcel G</creatorcontrib><creatorcontrib>Duettmann, Wiebke</creatorcontrib><creatorcontrib>Halleck, Fabian</creatorcontrib><creatorcontrib>Merkel, Marina</creatorcontrib><creatorcontrib>Schrezenmeier, Eva</creatorcontrib><creatorcontrib>Waiser, Johannes</creatorcontrib><creatorcontrib>Duerr, Michael</creatorcontrib><creatorcontrib>Budde, Klemens</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mayrdorfer, Manuel</au><au>Liefeldt, Lutz</au><au>Wu, Kaiyin</au><au>Rudolph, Birgit</au><au>Zhang, Qiang</au><au>Friedersdorff, Frank</au><au>Lachmann, Nils</au><au>Schmidt, Danilo</au><au>Osmanodja, Bilgin</au><au>Naik, Marcel G</au><au>Duettmann, Wiebke</au><au>Halleck, Fabian</au><au>Merkel, Marina</au><au>Schrezenmeier, Eva</au><au>Waiser, Johannes</au><au>Duerr, Michael</au><au>Budde, Klemens</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exploring the Complexity of Death-Censored Kidney Allograft Failure</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><addtitle>J Am Soc Nephrol</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>32</volume><issue>6</issue><spage>1513</spage><epage>1526</epage><pages>1513-1526</pages><issn>1046-6673</issn><eissn>1533-3450</eissn><abstract>Few studies have thoroughly investigated the causes of kidney graft loss (GL), despite its importance. A novel approach assigns each persistent and relevant decline in renal function over the lifetime of a renal allograft to a standardized category, hypothesizing that singular or multiple events finally lead to GL. An adjudication committee of three physicians retrospectively evaluated indication biopsies, laboratory testing, and medical history of all 303 GLs among all 1642 recipients of transplants between January 1, 1997 and December 31, 2017 at a large university hospital to assign primary and/or secondary causes of GL. In 51.2% of the patients, more than one cause contributed to GL. The most frequent primary or secondary causes leading to graft failure were intercurrent medical events in 36.3% of graft failures followed by T cell-mediated rejection (TCMR) in 34% and antibody-mediated rejection (ABMR) in 30.7%. In 77.9%, a primary cause could be attributed to GL, of which ABMR was most frequent (21.5%). Many causes for GL were identified, and predominant causes for GL varied over time. GL is often multifactorial and more complex than previously thought.</abstract><cop>United States</cop><pub>American Society of Nephrology</pub><pmid>33883251</pmid><doi>10.1681/ASN.2020081215</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-6063-2806</orcidid><orcidid>https://orcid.org/0000-0001-5236-2749</orcidid><orcidid>https://orcid.org/0000-0003-3872-3477</orcidid><orcidid>https://orcid.org/0000-0002-7929-5942</orcidid><orcidid>https://orcid.org/0000-0002-6988-8269</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1046-6673
ispartof Journal of the American Society of Nephrology, 2021-06, Vol.32 (6), p.1513-1526
issn 1046-6673
1533-3450
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8259637
source PubMed Central (Open Access); Elektronische Zeitschriftenbibliothek
subjects Adult
Aged
Allografts - pathology
Allografts - physiopathology
Allografts - statistics & numerical data
Calcineurin Inhibitors - adverse effects
Cardio-Renal Syndrome - complications
Clinical Research
Databases, Factual
Death
Female
Graft Rejection - immunology
Graft Rejection - prevention & control
Graft Survival
Humans
Immunity, Cellular
Immunity, Humoral
Immunosuppressive Agents - therapeutic use
Kidney Failure, Chronic - surgery
Kidney Transplantation - standards
Kidney Transplantation - statistics & numerical data
Male
Medication Adherence - statistics & numerical data
Middle Aged
Polyomavirus Infections - complications
Recurrence
Retrospective Studies
Survival Rate
T-Lymphocytes
Thrombosis - complications
Time Factors
Tumor Virus Infections - complications
title Exploring the Complexity of Death-Censored Kidney Allograft Failure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T14%3A44%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exploring%20the%20Complexity%20of%20Death-Censored%20Kidney%20Allograft%20Failure&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Mayrdorfer,%20Manuel&rft.date=2021-06-01&rft.volume=32&rft.issue=6&rft.spage=1513&rft.epage=1526&rft.pages=1513-1526&rft.issn=1046-6673&rft.eissn=1533-3450&rft_id=info:doi/10.1681/ASN.2020081215&rft_dat=%3Cpubmed_cross%3E33883251%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-4dfb3f0cb88155a6e45634b4b52a68aabbdefc4e814e6b81443545a88d616d053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/33883251&rfr_iscdi=true